benzothiophene has been researched along with Breast Neoplasms in 9 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (11.11) | 29.6817 |
2010's | 5 (55.56) | 24.3611 |
2020's | 3 (33.33) | 2.80 |
Authors | Studies |
---|---|
Bai, C; Dong, H; Hao, H; Li, Z; Luo, G; Lv, Y; Qi, L; Ren, S; Shen, H; Wu, S; Xiang, H; Xiao, Y; Xiong, S; Ye, H; Zhu, M; Zhu, Y | 1 |
Barbarossa, A; Caruso, A; Ceramella, J; Dallemagne, P; El-Kashef, H; Grande, F; Iacopetta, D; Occhiuzzi, MA; Rault, S; Rizzuti, B; Saturnino, C; Sinicropi, MS | 1 |
Chen, H; Dubrovyskyii, O; Dye, K; Gordon-Blake, J; Gutgesell, LM; He, D; Hollas, M; Huang, F; Lasek, AW; Lee, S; Li, Y; Lu, Y; Rosales, CI; Shen, Z; Thatcher, GRJ; Tonetti, DA; Wang, Y; Xiong, R; Zhao, H; Zhao, J | 1 |
Barakat, A; Boraei, ATA; Eltamany, EH; Gad, EM; Hammad, MSAG; Nafie, MS | 1 |
Bai, C; Luo, G; Ren, S; Wu, S; Xiang, H; Zhu, M | 1 |
Cherkasov, A; Dalal, K; Lallous, N; Munuganti, RSN; Rennie, PS; Sharma, A; Singh, K; Yamazaki, T; Yoon, JS | 1 |
Gherezghiher, T; Jordan, VC; Maximov, PY; Michalsen, BT; Molloy, ME; Patel, H; Thatcher, GR; Tonetti, DA; White, BE; Xiong, R; Zhao, H | 1 |
Gutgesell, LM; Karumudi, B; Lee, S; Lu, Y; Thatcher, GR; Tonetti, DA; Wang, Y; Xiong, R; Zhao, H; Zhao, J | 1 |
Cooperwood, JS; Khan, MO; Musa, MA | 1 |
1 review(s) available for benzothiophene and Breast Neoplasms
Article | Year |
---|---|
Medicinal chemistry and emerging strategies applied to the development of selective estrogen receptor modulators (SERMs).
Topics: Breast Neoplasms; Drug Design; Estrogen Receptor alpha; Female; Humans; Raloxifene Hydrochloride; Receptors, Estrogen; Selective Estrogen Receptor Modulators; Stilbenes; Structure-Activity Relationship; Tamoxifen; Thiophenes; Toremifene | 2007 |
8 other study(ies) available for benzothiophene and Breast Neoplasms
Article | Year |
---|---|
X-ray crystallography study and optimization of novel benzothiophene analogs as potent selective estrogen receptor covalent antagonists (SERCAs) with improved potency and safety profiles.
Topics: Animals; Breast Neoplasms; Crystallography, X-Ray; Estrogen Antagonists; Estrogen Receptor alpha; Estrogen Receptor Antagonists; Female; Humans; MCF-7 Cells; Mice; Receptors, Estrogen | 2023 |
Benzothienoquinazolinones as new multi-target scaffolds: Dual inhibition of human Topoisomerase I and tubulin polymerization.
Topics: Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; DNA Topoisomerases, Type I; Drug Design; Female; Humans; Molecular Docking Simulation; Quinazolinones; Thiophenes; Topoisomerase I Inhibitors; Tubulin; Tubulin Modulators | 2019 |
Design and Synthesis of Basic Selective Estrogen Receptor Degraders for Endocrine Therapy Resistant Breast Cancer.
Topics: Animals; Apoptosis; Aromatase Inhibitors; Breast Neoplasms; Cell Proliferation; Drug Design; Drug Resistance, Neoplasm; Estrogen Receptor alpha; Female; Humans; Mice; Mice, Inbred C57BL; Mice, Nude; Mutation; Proteolysis; Rats; Rats, Sprague-Dawley; Selective Estrogen Receptor Modulators; Thiophenes; Tissue Distribution; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2019 |
Discovery of New Apoptosis-Inducing Agents for Breast Cancer Based on Ethyl 2-Amino-4,5,6,7-Tetra Hydrobenzo[
Topics: Alkylation; Antineoplastic Agents; Apoptosis; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Hep G2 Cells; Humans; MCF-7 Cells; Pyrimidinones; Structure-Activity Relationship; Thiophenes | 2020 |
Design and synthesis of novel benzothiophene analogs as selective estrogen receptor covalent antagonists against breast cancer.
Topics: Antineoplastic Agents; Apoptosis; Breast Neoplasms; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Drug Design; Drug Screening Assays, Antitumor; Estrogen Receptor Antagonists; Female; Humans; MCF-7 Cells; Molecular Structure; Receptors, Estrogen; Structure-Activity Relationship; Thiophenes; Tumor Cells, Cultured | 2021 |
Benzothiophenone Derivatives Targeting Mutant Forms of Estrogen Receptor-α in Hormone-Resistant Breast Cancers.
Topics: Binding Sites; Breast Neoplasms; Cell Proliferation; Chromatin; Drug Resistance, Neoplasm; Estrogen Receptor alpha; Female; Gene Expression Regulation, Neoplastic; Humans; MCF-7 Cells; Mutation; Protein Binding; Tamoxifen; Thiophenes | 2018 |
Novel selective estrogen mimics for the treatment of tamoxifen-resistant breast cancer.
Topics: Animals; Apoptosis; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Disease Progression; Estrogens; Female; Humans; MCF-7 Cells; Mice; Mice, Nude; Random Allocation; Receptors, Estrogen; Tamoxifen; Thiophenes; Transfection; Xenograft Model Antitumor Assays | 2014 |
Novel Selective Estrogen Receptor Downregulators (SERDs) Developed against Treatment-Resistant Breast Cancer.
Topics: Animals; Antineoplastic Agents, Hormonal; Breast; Breast Neoplasms; Cell Line, Tumor; Drug Resistance, Neoplasm; Female; Humans; Mice, Nude; Models, Molecular; Neoplasms, Hormone-Dependent; Receptors, Estrogen; Selective Estrogen Receptor Modulators; Thiophenes | 2017 |